» Articles » PMID: 19874308

Severe Liver Dysfunction from Hepatitis C Virus Reactivation Following Alemtuzumab Treatment for Chronic Lymphocytic Leukaemia

Overview
Journal Br J Haematol
Specialty Hematology
Date 2009 Oct 31
PMID 19874308
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

Basics and Art of Immunosuppression in Liver Transplantation.

Poudel S, Gupta S, Saigal S J Clin Exp Hepatol. 2024; 14(3):101345.

PMID: 38450290 PMC: 10912712. DOI: 10.1016/j.jceh.2024.101345.


The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review.

Biolato M, Bianco A, Lucchini M, Gasbarrini A, Mirabella M, Grieco A CNS Drugs. 2021; 35(8):861-880.

PMID: 34319570 PMC: 8354931. DOI: 10.1007/s40263-021-00842-9.


Severe hepatitis C reactivation as an early complication of hematopoietic cell transplantation.

Oliver N, Nieto Y, Blechacz B, Anderlini P, Ariza-Heredia E, Torres H Bone Marrow Transplant. 2016; 52(1):138-140.

PMID: 27427916 DOI: 10.1038/bmt.2016.196.


Hepatitis C virus reactivation in cancer patients in the era of targeted therapies.

Yazici O, Sendur M, Aksoy S World J Gastroenterol. 2014; 20(22):6716-24.

PMID: 24944464 PMC: 4051913. DOI: 10.3748/wjg.v20.i22.6716.


Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

Torres H, Davila M Nat Rev Clin Oncol. 2012; 9(3):156-66.

PMID: 22271089 DOI: 10.1038/nrclinonc.2012.1.